Actinium Pharmaceuticals
ATNM
#10580
Rank
$33.32 M
Marketcap
$1.06
Share price
-3.64%
Change (1 day)
-34.16%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): $9.55 Million USD

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are $35.09 Million USD. In 2025 the company made an earning of -$36.25 Million USD, an increase over its 2024 earnings that were of -$42.13 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $9.55 M-126.36%
2025 -$36.25 Million-13.95%
2024 -$42.13 Million-18.87%
2023 -$51.92 Million52.24%
2022 -$34.11 Million36.61%
2021 -$24.97 Million11.48%
2020 -$22.4 Million1.46%
2019 -$22.08 Million-7.37%
2018 -$23.83 Million-11.46%
2017 -$26.92 Million10.67%
2016 -$24.32 Million15.7%
2015 -$21.02 Million-14.86%
2014 -$24.69 Million129.19%
2013 -$10.78 Million-8.55%
2012 -$11.78 Million
2010 $0 M-152.15%
2009 -$0.02 Million-39.8%
2008 -$0.03 Million120.29%
2007 -$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-$37.2 Million-489.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$0.19 M-98.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$0.14 B 1,460.38%๐Ÿ‡บ๐Ÿ‡ธ USA